![](https://endpts.com/wp-content/uploads/2024/02/Chris-Varma.jpg)
Chris Varma, Frontier Medicines CEO
Frontier Medicines raises $80M, enters clinic and eyes potential IPO in Q4 or early 2025
Frontier Medicines, a bicoastal biotech creating covalent small molecules, has secured $80 million in Series C funds and dosed the first patient in its initial …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.